Cost of Disrupted Clinical Research Due to COVID-19 Equates to $10+ Billion & Potential Study Delays

Press/Media

Period	22 Jul 2020

Media coverage

Title	Cost of Disrupted Clinical Research Due to COVID-19 Equates to $10+ Billion & Potential Study Delays
Media name/outlet	Drug Development & Delivery
Country/Territory	United States
Date	22/07/20
URL	https://drug-dev.com/cost-of-disrupted-clinical-research-due-to-covid-19-equates-to-10-billion-potential-study-delays/
Persons	Alex Limkaken